To the Editor We read with interest the article from Vaidya et al1 on the 5-year outcomes after delayed second-procedure targeted intraoperative radiotherapy (IORT). Unfortunately, the term IORT is often used in a too generalized way, making it prone to confuse the reader in discriminating 50-kV endocavitary x-rays, like in the TARGIT-A trial, from intraoperatively delivered electron radiotherapy (IOERT).
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Fastner G, Leonardi MC, Poortmans PM. Targeted Intraoperative Radiotherapy for Early Breast Cancer. JAMA Oncol. 2020;6(10):1636–1637. doi:10.1001/jamaoncol.2020.2719
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: